Xilio Therapeutics, Inc. financial statements
Xilio Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 43.77M | 10-K |
| Net income | −USD 35.04M | 10-K |
| Cash and equivalents | USD 137.53M | 10-Q |
| Total debt | USD 6.95M | EODHD |
Xilio Therapeutics, Inc. financials on 6ix · Xilio Therapeutics, Inc. on 6ix